Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted 2-anilinopyrimidine derivatives as EGFR modulators

Substituted 2-anilinopyrimidine derivatives as EGFR modulators

US Patent 10590111 · Granted Mar 17, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Protein degradation agent compound preparation method and application2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Pharmaceutical formulations of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(12025